📰 Expanded Access News
Page 13 - Expanded Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access. Real-time updates on events, politics, business and more.
August 2, 2022
A drug is available for monkeypox patients who have or who are at risk of severe disease, but doctors say they continue to face challenges getting access to it. The U.S. Food and Drug Administration hasnt approved tecovirimat -- sold under the brand name Tpoxx -- specifically for use against monkeypox, but the U.S. Centers for Disease Control and Prevention has made the drug available.
July 29, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an update on its multipronged response to monkeypox in the United States, including...
July 29, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an update on its multipronged response to monkeypox in the United States, including...
July 27, 2022
Vaccine supply to Riverside County has been scarce, but Coachella Valley clinics are starting to receive doses.
July 27, 2022
Many at the meeting said ample treatment options should have already been available in the valley, especially given its high concentration of men who have sex with men.
July 26, 2022
Jynneos is a live, nonreplicating, smallpox and monkeypox vaccine; ACAM2000 is a live smallpox (vaccinia) vaccine.
June 13, 2022
This Viewpoint summarizes current knowledge of the 2022 monkeypox virus outbreak and the pathology, symptoms, diagnosis, prevention measures, and treatment opti
June 9, 2022
Zacks Small-Cap Research Note By John D. Vandermosten, CFA NEW YORK, June 09, 2022positive clinical results for its second secondary progressive multiple sclerosis. Based on the data gathered
June 9, 2022
Research Note Clinical Results for Second SPMS Patient NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences PLC (NASDAQ: TLSA)...
June 9, 2022
Research Note Clinical Results for Second SPMS Patient NEW YORK, June 09, 2022positive clinical results for its second secondary progressive multiple sclerosis. Based on the data gathered from